BABA
Alibaba Group Holding Limited
BABA has the edge over GENK overall, supported by lower modeled downside and stronger fundamentals.
GENK
GEN Restaurant Group, Inc.
GENK offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
GENK Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Under pressure | |
| Strong |
GENK's balance sheet is currently strong, and its revenue is stable, but its profitability and cash flow are under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
GENK PE Valuation
GENK has no meaningful PE right now: it lost money over the past year.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
BABA has the edge over GENK on the outlook, with more favorable revenue and profitability expectations.
GENK Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect GENK's losses to shrink, with revenue holding steady.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA has the edge over GENK on earnings quality, reporting a profit while its opponent remains loss making.
GENK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.89 | -$0.62 |
| Q2 2026 | -$0.84 | -$0.69 |
| Q1 2026 | -$0.75 | -$0.71 |
| Q4 2025 | -$0.59 | -554% |
| Q3 2025 | -$0.27 | -259% |
| Q2 2025 | -$0.15 | -163% |
| Q1 2025 | -$0.04 | -104% |
| Q4 2024 | $0.13 | -94% |
GENK lost $0.89 per share over the past year, and its loss has widened in each of the last 11 quarters.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA has the edge over GENK on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over GENK on profitability, with a higher operating margin.
GENK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $48.7M | -3.3% |
| Q2 2026 | $55.7M | +1.2% |
| Q1 2026 | $53.9M | -6% |
| Q4 2025 | $49.7M | -9% |
| Q3 2025 | $50.4M | +2.7% |
| Q2 2025 | $55M | +2.2% |
| Q1 2025 | $57.3M | +13% |
| Q4 2024 | $54.7M | +21% |
GENK's revenue is shrinking: $49M last quarter, down 3.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -12% | -5 points |
| Q2 2026 | -9.2% | -5.8 points |
| Q1 2026 | -13% | -9.6 points |
| Q4 2025 | -25% | -22 points |
| Q3 2025 | -7.4% | -7.6 points |
| Q2 2025 | -3.4% | -6.4 points |
| Q1 2025 | -3.8% | -4 points |
| Q4 2024 | -2.4% | -0.4 points |
GENK's operating margin was −12% last quarter, down 5 points from the same quarter a year ago, near the bottom of its range since 2020.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
GENK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.9M | +$767K |
| Q2 2026 | -$5.5M | +$835K |
| Q1 2026 | -$667K | +$4M |
| Q4 2025 | -$5.6M | -3516% |
| Q3 2025 | -$7.7M | -$870K |
| Q2 2025 | -$6.3M | -605% |
| Q1 2025 | -$4.7M | -$4.1M |
| Q4 2024 | $165K | -83% |
GENK has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has the edge over GENK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
GENK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +17% | +935K shares |
| 1 year | +20% | +1.1M shares |
| 3 years | +52% | +2.2M shares |
| 5 years | +75% | +2.7M shares |
GENK has 6M diluted shares, up 20% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $1,000 |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $200,000 |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $320,000 |
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
GENK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -1.6x | Net Cash |
| Q4 2024 | -2.3x | Net Cash |
| Q3 2024 | -2.1x | Net Cash |
| Q2 2024 | -2.4x | Net Cash |
| Q1 2024 | -2.0x | Net Cash |
| Q4 2023 | -1.8x | Net Cash |
| Q3 2023 | -1.6x | Net Cash |
GENK has more cash than debt.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
GENK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.8 | Oversold |
| Stochastic | 5.4 | Oversold |
GENK's weekly RSI is 26 (oversold) and its Stochastic is 5 (oversold).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA is trading at 21x earnings, a 19% premium to the Consumer Cyclical sector's median of 18x, though its earnings don't support one.
GENK PE vs Consumer Cyclical Sector
| Metric | GENK | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
GENK has no meaningful PE right now: it lost money over the past year.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
GENK has stronger trend alignment. BABA is above 0 of 5 weekly averages versus GENK above 0 of 4.
GENK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.49 | 36% below |
| 20 week MA | $1.75 | 45% below |
| 50 week MA | $1.91 | 50% below |
| 100 week MA | $3.17 | 70% below |
GENK is in a downtrend: it's below all four of its weekly moving averages, and 70% below its 100-week average.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has the edge over GENK on returns for 2026, with the stronger performance.
GENK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $17.0 | $7.83 | -54% |
| 2024 | $7.83 | $7.40 | -5.5% |
| 2025 | $7.40 | $2.41 | -67% |
| 2026 YTD | $2.41 | $0.96 | -60% |
GENK has finished every year since 2023 lower, and it's down 60% so far in 2026.